Stay updated on BMN 111 in Achondroplasia Children Clinical Trial
Sign up to get notified when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.

Latest updates to the BMN 111 in Achondroplasia Children Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedLocations have been reorganized under a single 'Locations' section, listing sites by state and country. The previous multiple state-specific location subsections have been consolidated.SummaryDifference1%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedFooter now displays Revision: v3.3.2, updated from v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedPublications are now described as automatically filled from PubMed. The revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the government funding lapse notice from the study page, which previously warned that information might not be up to date and provided operating status links. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check65 days agoChange DetectedThe screenshots indicate only minor formatting adjustments with no substantive changes to the study record (criteria, endpoints, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference3%

Stay in the know with updates to BMN 111 in Achondroplasia Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 111 in Achondroplasia Children Clinical Trial page.